FDA takes first step in possible reversal of ban on some peptides The Washington Post FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions